Sign in
Taking people in United StatesNo phase

fMRI and Opioid Abstinence

Key facts

Who runs it
Yale University
Where
Hartford and New Haven, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
240 people, planned
Started
12 Dec 2024
Expected to end
Nov 2029
Type of study
Observational, 2 groups
Treatments tested
  • fMRI
Record updated
7 August 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • recent initiation of methadone or buprenorphine at a clinic, program, or doctor within the past year (i.e., period of time during which treatment drop-out and risk for relapse is highest)
  • eligibility for MRI scanning
  • ability to commit to study visits

Who cannot take part

  • severe cognitive impairment as determined via trained clinical research staff through consent process and during consent quiz or as indicated by a PROMIS Cognitive Function tscore <30 (i.e., severe impairment)
  • past or present history of intellectual disability, developmental disorder, or neurological disease
  • organ dysfunction or any unstable or untreated medical conditions that may interfere with study participation
  • current acute psychosis, mania, or suicidal ideation with intent, as assessed during screening with the SCID-5
  • current intoxication or acute withdrawal at time of study visit sufficient to prevent participation based on: behavioral observation, breathalyzer, and SOWS assessment
  • head trauma with loss of consciousness >30 min

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

This trial is currently available in United States.

  • Hartford HealthcareHartford, United StatesContact: Monica HollerTaking people
  • The APT FoundationNew Haven, United StatesContact: Monica HollerTaking people

About the trial

What the trial wants to find out

This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.

The 2 groups in the trial

  • Methadone

    Participants initiated into methadone within the past 6 months will receive fMRI and cognitive assessment battery.

    Treatment: fMRI

  • Buprenorphrine

    Participants initiated into buprenorphine within the past 6 months will receive fMRI and cognitive assessment battery.

    Treatment: fMRI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Functional Connectivity Mechanisms of Opioid Abstinence
Criteria questions
Built from NCT06651333, who can take part
Record updated
7 August 2026